Yvonne Ou, MD, a professor of ophthalmology at the University of California San Francisco, spoke about lifestyle modifications for glaucoma at this year's Glaucoma 360 meeting.
Researchers introduce a multistage dual-branch network to improve accuracy and efficiency
Research explores innovative physiotherapeutic approaches to managing myopia progression, showing promising results in slowing its advancement over two years.
Adrienne Graves, PhD, and Andrew Iwach, MD, co-founders of Glaucoma 360, highlight the 13th annual Glaucoma 360 New Horizons Forum, held this year at the Westin St. Francis San Francisco on Union Square.
Katrina Ronne shares her vision to empower ophthalmologists, champion equity, and strengthen advocacy for better eye health outcomes across Australia.
Physicians should consider the roles of verbal and ocular anesthesia.
Case of anterior segment ischemia involves young adult with prior carotid artery injury.
Discover how advocacy can impact your clinical work and ultimately patient care.
Removing drops from procedure increases adherence and comfort for most patients.
Staging AMD accurately and identifying clinical features that are linked with disease progression are key.
Over the years, IKA has become an invaluable resource for eye care professionals.
From revised patient flow to smarter tech adoption, ophthalmologists share which changes from 2020 have become cornerstones of modern care—and how they’re preparing for the next big disruption
Evidence-based medicine can lead to personalized care, better results for patients
Technical details, communication style key to presbyopia-correcting IOL journey.
Optimizing corneal neurotization outcomes with cryopreserved amniotic membrane.
Research can drive opportunities for patients with rare diseases
Considerations in the treatment of diabetic retinopathy and diabetic macular edema.
These tools help fill a gap that current technologies cannot achieve as effectively.
Epi-on corneal crosslinking is advancing through innovations like supplemental oxygen, chemical oxygenation, and laser-assisted techniques.
Grazia Pertile, MD, discusses the highlights of her presentations on the management of retinal folds after retinal detachment and the role of the anterior vitreous as a cause of recurrent retinal detachment.
Ophthalmologist offers pearls for use of technology in daily work.
A discussion with Shigeru Kinoshita, MD, PhD; and Edward J. Holland, MD.
Retinal specialists conclude their discussion with key highlights from each patient case of retinal vascular disease and pearls the audience can apply in their practice.
Randomly assigned controlled trials key in increasing understanding of disease.
Laxmi Devisetty, MD, and Eva Kim, MD, look ahead at upcoming sessions focusing on geographic atrophy and refractive and cataract surgery at the Envision Summit 2025.
At the Envision Summit 2025 in San Juan, Puerto Rico, Sara Wester, MD, discussed the Women Leaders in Eye Health session at the conference and the donation from Orbis that supported the session.
Direct selective laser trabeculoplasty enhances the experience for both patients and physicians, he notes, while also mitigating issues related to poor adherence and ocular surface disease from topical therapy.
Wendy Lee, MD, an oculoplastics specialist and member of the program committee at EnVision Summit, shares an agenda that will include a mix of functional oculoplastics, aesthetics, and live facial rejuvenation demonstrations at the upcoming event, which will be held from February 14 to 17, 2025, at the Caribe Hilton San Juan in Puerto Rico.
Paul Badawi, co-founder and CEO of Sight Sciences, sits down with host Neda Shamie, MD, to discuss his journey into the field of eye care, what motivates him, the transformative approach to glaucoma patient care, and the spark that led him and his ophthalmologist brother, David Badawi, MD, to start the company together.